Cargando…
A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; Expanding the use of Vi polysaccharide vaccine in Southeast China: A cluster-randomized trial
BACKGROUND: One of the goals of this study was to learn the coverage, safety and logistics of a mass vaccination campaign against typhoid fever in children and adults using locally produced typhoid Vi polysaccharide (PS) and group A meningococcal PS vaccines in southern China. METHODS: The vaccinati...
Autores principales: | Yang, Jin, Acosta, Camilo J, Si, Guo-ai, Zeng, Jun, Li, Cui-yun, Liang, Da-bin, Ochiai, R Leon, Page, Anne-Laure, Danovaro-Holliday, M Carolina, Zhang, Jie, Zhou, Bao-de, Liao, He-zhuang, Wang, Ming-liu, Tan, Dong-mei, Tang, Zhen-zhu, Gong, Jian, Park, Jin-Kyung, Ali, Mohammad, Ivanoff, Bernard, Liang, Gui-chen, Yang, Hong-hui, Pang, Tikki, Xu, Zhi-yi, Donner, Allan, Galindo, Claudia M, Dong, Bai-qing, Clemens, John D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1156911/ https://www.ncbi.nlm.nih.gov/pubmed/15904514 http://dx.doi.org/10.1186/1471-2458-5-49 |
Ejemplares similares
-
25 Years after Vi Typhoid Vaccine Efficacy Study, Typhoid Affects Significant Number of Population in Nepal
por: Bajracharya, Deepak, et al.
Publicado: (2014) -
Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study
por: Bilcke, Joke, et al.
Publicado: (2019) -
Use of Typhoid Vi-Polysaccharide Vaccine as a Vaccine Probe to Delineate Clinical Criteria for Typhoid Fever
por: Islam, Md. Taufiqul, et al.
Publicado: (2020) -
Lessons and implications from a mass immunization campaign in squatter settlements of Karachi, Pakistan: an experience from a cluster-randomized double-blinded vaccine trial [NCT00125047]
por: Khan, Mohammad Imran, et al.
Publicado: (2006) -
Implementation of an outbreak response vaccination campaign with typhoid conjugate vaccine – Harare, Zimbabwe, 2019
por: Poncin, M., et al.
Publicado: (2022)